The Spine Biologics market is on the brink of significant growth, with projections indicating it will surpass USD 3.5 billion by 2033, showcasing a steady CAGR of 4.2% between 2023 and 2031. Several key factors are driving investor interest in this sector. The demographic shift toward an aging population, combined with a growing prevalence of …
